US2014326812A1PendingUtilityA1

Method for the Production of Commercial Nanoparticle and Microparticle Powders

63
Assignee: ICEUTICA PTY LTDPriority: Apr 24, 2009Filed: May 15, 2014Published: Nov 6, 2014
Est. expiryApr 24, 2029(~2.8 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 29/00A23L 33/10A01N 25/10A01N 47/36A61K 31/18A61K 31/196A23P 10/20A61K 9/1617A61K 9/1635A61K 31/4709A23V 2002/00A61K 9/0075A61K 31/57A61K 31/198A61K 31/53A61K 9/1682B02C 17/20B02C 19/0056A61K 38/13A23P 10/30A61K 9/145A61K 9/14A61K 31/496A01N 25/34A61K 31/5415A61K 31/415A61K 47/50A01N 55/02A61K 31/405A61K 9/146A61K 31/565A61K 31/421A61K 31/137A01N 37/38A61K 9/1652A61K 31/404A61K 31/497A61P 11/00A01N 25/12A01N 57/20A61K 9/1623A61K 9/16A61K 31/122A61K 33/04A61J 3/02A61K 31/192A01N 59/02A01N 57/12A01N 47/14A01N 39/04
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to methods for producing nanoparticle and microparticle powders of a biologically active material which have improved powder handling properties making the powders suitable for commercial use using dry milling processes as well as compositions comprising such materials, medicaments produced using said biologically active materials in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of said biologically active materials administered by way of said medicaments.

Claims

exact text as granted — not AI-modified
1 . A method for producing nanoparticle and/or microparticle biologically active material with powder handling characteristics superior to powders made by conventional size reduction processes, wherein the said method comprises the steps of:
 dry milling a solid biologically active material and a millable grinding matrix in a mill comprising a plurality of milling bodies, for a time period sufficient to produce particles of the biologically active material dispersed in an at least partially milled grinding material.   
     
     
         2 - 47 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.